Ypsomed opens a new production line in Solothurn

Press Releases Ypsomed Group

Burgdorf – Following 18 months of industrialisation, Ypsomed opened its new production line in their Solothurn works and will have created over 50 new jobs on final expansion. The inauguration was held yesterday with representatives of local commerce and guests from politics in attendance.

Press Releases Ypsomed Group

Burgdorf – On 11 January 2017, Ypsomed was honoured with the 20th Solothurn Business Award. Ypsomed received an award for their outstanding business performance in the canton of Solothurn in terms of implementing modern work models and for its commitment to promoting the production location in Switzerland. The ceremony was held in front of over 350 attendees representing commerce, politics and administration.

Press Releases Ypsomed Group

Burgdorf – The human insulin of Russian pharmaceutical company GEROPHARM will in future be administered with a pen from Ypsomed's ServoPen® platform. This is a further confirmation of Ypsomed's platform strategy in the field of injection systems.

Press Releases Ypsomed Group

Burgdorf – The human insulin of Russian pharmaceutical company GEROPHARM will in future be administered with a pen from Ypsomed's ServoPen® platform. This is a further confirmation of Ypsomed's platform strategy in the field of injection systems.

Press Releases Ypsomed Group

Burgdorf – Austrian specialist pharmaceutical company, Ever Pharma, now offers the D-mine Pen for the treatment of Parkinson patients with apomorphine. This reusable pen, which is based on the Ypsomed ServoPen platform, facilitates subcutaneous administration with its patient friendly design.